GENESIS Pharma has been awarded with the 'Committed to Excellence in Europe' EFQM award

GENESIS Pharma achieved the honourable distinction "Committed to Excellence in Europe" by EFQM after having successfully completed the first of the three EFQM Levels of Excellence.

Mr. Constantinos Evripides, CEO, GENESIS Pharma, stated: "Adopting the best practices that support our company's optimum performance has always been part of our corporate philosophy. This honourable distinction endorses the commitment to our vision 'to be the best pharmaceutical company'. I'm convinced that our participation in the EFQM Levels of Excellence will be our guide to this beautiful business excellence journey and will lead us to the continuous improvement of our operations."